Notice Type
Departmental
Notice Title

Notice of Reassessment of Registered Trade Name Products (Notice No. MPI 986)

I, Maree Zinzley, Manager Approvals Operations, of the Ministry for Primary Industries (MPI), acting under delegated authority from the Director-General of MPI, give notice, under section 14(1) of the Agricultural Compounds and Veterinary Medicines Act 1997 (“Act”), that a decision has been made to reassess the following trade name products under section 29 of the Act.

Purpose of Reassessment

The reassessment of the trade name products listed below are to establish whether a condition should be imposed on the registration of each of the trade name products listed below. Those trade name products are all antibiotics. The proposed condition would prohibit the advertising of the trade name product, being an antibiotic, to the end-users.

The Trade Name Products to be Reassessed are:

Reference

Trade Name

Active ingredients and concentrations

A001749

TETRAVET 100 SOLUBLE ANTIBIOTIC POWDER

Oxytetracycline Hydrochloride,

A005092

DryClox AF

Ampicillin, Cloxacillin Benzathine,

A005544

GENTAVET 100.

Gentamicin,

A005581

BAYTRIL 10% INJECTABLE SOLUTION

Enrofloxacin,

A005729

BAYTRIL 15

Enrofloxacin,

A005730

BAYTRIL 50 flavour Antibacterial Tablets

Enrofloxacin,

A005731

BAYTRIL 150 flavour Antibacterial Tablets

Enrofloxacin,

A005732

BAYTRIL 2.5% INJECTABLE SOLUTION

Enrofloxacin,

A005893

ERYTHROSOL

Erythromycin,

A006811

DC Xtra AF

Ampicillin, Cloxacillin Benzathine,

A006892

TETRAVET SPRAY

Gentian Violet, Oxytetracycline Hydrochloride,

A007066

TRISULFIN ANTIBACTERIAL BOLUS

Sulfadiazine, Trimethoprim,

A007453

TETRAVET AEROSOL

Gentian Violet, Oxytetracycline Hydrochloride,

A007485

TETRAVET BLUE

Oxytetracycline Hydrochloride,

A007555

TRISULFIN SUSPENSION

Kaolin, Pectin, Potassium Chloride, Sodium Chloride, Sulfadiazine, Trimethoprim,

A007958

BAYTRIL OTIC

Enrofloxacin, Silver Sulfadiazine,

A009423

Penethaject

Penethamate Hydriodide,

A009626

Scourban Plus

Calcium Gluconate ( Mixture Of Isomers), Glycine, Hyoscine Hydrobromidetri-Hydrate, Kaolin, Magnesium Sulfate, Pectin, Potassium Chloride, Sodium Chloride, Sulfadiazine, Sulphaguanidine, Sulphamethazine,

A009768

Lactapen

Penicillin G Procaine,

A009860

Lactapen G

Penicillin G Procaine,

A009912

Lactaclav

Amoxycillin Present As Amoxycillin Trihydrate, Clavulanic Acid Present As Potassium Clavulanate, Prednisolone,

A010006

Tyloject

Tylosin,

A010050

Clavobay LC

Amoxycillin Present As Amoxycillin Trihydrate, Clavulanic Acid Present As Potassium Clavulanate,

A010064

Cepha-Forte DC

Cephalonium,

A010099

Tetravet 100 PVP

Oxytetracycline Hydrochloride,

A010129

Tetravet 100 Flexidose

Oxytetracycline Hydrochloride, Oxytetracycline Present As Oxytetracycline Hydrochloride,

A010130

Tetravet 200 SC

Oxytetracycline Present As Oxytetracycline Dihydrate,

A010184

Ceftiject

Ceftiofur Present As Ceftiofur Sodium,

A010313

Tylosin Base Injection

Tylosin,

A010314

Bomacure

Cephapirin Benzathine,

A010418

Ceftiject RTU

Ceftiofur Present As Ceftiofur Hydrochloride,

A010504

Baytril 25 Flavour Antibacterial Oral Suspension

Enrofloxacin,

A010610

Florfenicol Premix

Florfenicol,

A010614

Procaine Penicillin 30

Penicillin G Benzathine, Penicillin G Procaine,

A010697

Cefaject

Ceftiofur,

A010714

Tylosin 300 Injection

Tylosin,

A010772

Tylofen

Ketoprofen, Tylosin,

A010792

Ultraclox 24

Cloxacillin,

A010920

Penethaject RTU

Penethamate Hydriodide,

A010927

Veraflox Tablets for Dogs and Cats

Pradofloxacin,

A011125

Dryclox Xtra

Ampicillin Trihydrate, Cloxacillin Benzathine,

A011126

Dryclox DC

Ampicillin Trihydrate, Cloxacillin Benzathine,

A011156

Veraflox 25 mg/mL Oral Suspension for Cats

Pradofloxacin,

Further information about each of the trade name products listed above, including its intended use, can be found on the ACVM Register that is available on MPI’s website: https://eatsafe.nzfsa.govt.nz/web/public/acvm-register.

Any person may make a written submission to the director-general concerning this application.

Each submission must state the trade name product(s) the submission pertains to.

Under sections 16 and 17 of the Act, a written submission:

  1. must state in full the reasons for making the submission; and
  2. may state any decision sought on that application; and
  3. must be received by the director-general no later than 30 working days after the date of notification in the New Zealand Gazette.

Under section 18 of the Act, a copy of every submission will be forwarded to the registrant for the registrant’s information.

The following address is:

  1. where submissions on this application are to be sent; and
  2. where requests for copies of the public information relating to the application can be sent; and
  3. where public information relating to the application can be viewed; and
  4. the director-general’s address for service:

ACVM Group, Ministry for Primary Industries, Charles Fergusson Building, 34–38 Bowen Street, Pipitea, Wellington 6011. Postal Address: PO Box 2526, Wellington 6140.

The registrant’s address for service is:

Bayer New Zealand Limited, PO Box 2825, Shortland Street, Auckland 1140.

Dated at Wellington this 8th day of April 2019.

MAREE ZINZLEY, Manager Approvals Operations, Ministry for Primary Industries (acting under delegated authority).